Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 151 No. 0506 (2021)

Beware the inhaled steroids or corticophobia?

Cite this as:
Swiss Med Wkly. 2021;151:w20450


Inhaled corticosteroids have been the cornerstone of atopic, allergic asthma management for more than half a century. They have side effects (as does every medication), but they have transformed the control of asthma and saved many lives since their introduction. The current review revisits local and systemic side effects of inhaled corticosteroids and explores the prevalence and nature of parental fears (“corticophobia”) in different parts of the world. The empathetic physician treating asthma should bear in mind the impact of parental concerns on the management of this potentially life-threatening disease and try to dispel myths at every opportunity by emphasising the well-established benefits and excellent safety profile of inhaled corticosteroids.


  1. van Aalderen WM, Sprikkelman AB. Inhaled corticosteroids in childhood asthma: the story continues. Eur J Pediatr. 2011;170(6):709–18. doi:.
  2. Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;15(6):326–31. doi:.
  3. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400. doi:.
  4. Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, Malvezzi L, et al. Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. J Allergy Clin Immunol Pract. 2018;6(3):776–81. doi:.
  5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020. Available from:
  6. Rubin BK, Zhao W, Winders TA. What do patients want from their asthma care doctors? Paediatr Respir Rev. 2018;27:86–9. doi:.
  7. Abu-Shaheen AK, Nofal A, Heena H. Parental Perceptions and Practices toward Childhood Asthma. BioMed Res Int. 2016;2016:6364194. doi:.
  8. Zedan MM, Ezz El Regal M, A Osman E, E Fouda A. Steroid Phobia among Parents of Asthmatic Children: Myths and Truth. Iran J Allergy Asthma Immunol. 2010;9(3):163–8.
  9. Özçeker D, Uçkun U, İslamova D, Tamay Z, Güler N. Corticosteroid phobia among parents of asthmatic children. Turk J Pediatr. 2018;60(2):142–6. doi:.
  10. Hossny E, Rosario N, Lee BW, Singh M, El-Ghoneimy D, Soh JY, et al. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J. 2016;9:26. doi:.
  11. Bazzy-Asaad A. Safety of inhaled corticosteroids in children with asthma. Curr Opin Pediatr. 2001;13(6):523–7. doi:.
  12. Gulliver T, Morton R, Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Paediatr Drugs. 2007;9(3):185–94. doi:.
  13. Carlsen KH. Inhaled steroids and local side-effects. Allergy. 2001;56(10):925–7.
  14. Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, et al.; Réseau de Recherche Clinique en Pneumonologie Pédiatrique. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy. 2001;56(10):944–8. doi:.
  15. Camargos P, Zhang L, Lasmar L, Brand P. Question 2: What are the effects of inhaled corticosteroids on growth in children? Paediatr Respir Rev. 2018;28:33–40. doi:.
  16. Brook CG. Short stature never killed anybody. J Pediatr. 1998;133(5):591–2. doi:.
  17. Bush A. Inhaled corticosteroid and children’s growth. Arch Dis Child. 2014;99(3):191–2. doi:.
  18. Kapadia CR, Nebesio TD, Myers SE, Willi S, Miller BS, Allen DB, et al.; Drugs and Therapeutics Committee of the Pediatric Endocrine Society. Endocrine Effects of Inhaled Corticosteroids in Children. JAMA Pediatr. 2016;170(2):163–70. doi:.
  19. Wolfgram PM, Allen DB. Effects of Inhaled Corticosteroids on Growth, Bone Metabolism, and Adrenal Function. Adv Pediatr. 2017;64(1):331–45. doi:.
  20. Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev. 2014;7(4):CD009471. doi:.
  21. Pruteanu AI, Chauhan BF, Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth. Cochrane Database Syst Rev. 2014;9(4):CD009878. doi:.
  22. Bush A, Fleming L. 2012 and never been KISSed: we need to improve the care of children with asthma. Prim Care Respir J. 2012;21(3):242–4. doi:.
  23. Brand PL. Inhaled corticosteroids reduce growth. Or do they? Eur Respir J. 2001;17(2):287–94. doi:.
  24. Lemanske RF, Jr, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, et al.; Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975–85. doi:.
  25. Axelsson I, Naumburg E, Prietsch SO, Zhang L. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. Cochrane Database Syst Rev. 2019;6:CD010126. doi:.
  26. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, et al.; CAMP Research Group. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med. 2012;367(10):904–12. doi:.
  27. Zhang L, Lasmar LB, Castro-Rodriguez JA. The impact of asthma and its treatment on growth: an evidence-based review. J Pediatr (Rio J). 2019;95(Suppl 1):10–22. doi:.
  28. Cohen MB, Abram LE. Growth patterns of allergic children; a statistical study using the grid technique. J Allergy. 1948;19(3):165–71. doi:.
  29. Russell G. Childhood asthma and growth--a review of the literature. Respir Med. 1994;88(Suppl A):31–6, discussion 36–7. doi:.
  30. Ekins-Daukes S, Simpson CR, Helms PJ, Taylor MW, McLay JS. Burden of corticosteroids in children with asthma in primary care: retrospective observational study. BMJ. 2002;324(7350):1374. doi:.
  31. Allen DB. Inhaled corticosteroids and growth: still an issue after all these years. J Pediatr. 2015;166(2):463–9. doi:.
  32. Powell SG, Frydenberg M, Thomsen PH. The effects of long-term medication on growth in children and adolescents with ADHD: an observational study of a large cohort of real-life patients. Child Adolesc Psychiatry Ment Health. 2015;9(1):50. doi:.
  33. Lee HS, Wang SY, Salter DM, Wang CC, Chen SJ, Fan HC. The impact of the use of antiepileptic drugs on the growth of children. BMC Pediatr. 2013;13(1):211. doi:.
  34. Bayman E, Drake AJ. Adrenal suppression with glucocorticoid therapy: still a problem after all these years? Arch Dis Child. 2017;102(4):338–9. doi:.
  35. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87(6):457–61. doi:.
  36. Anurhada KWDA, Prematilake GLDC, Batuwita BAUI, Kannangoda KASR, Hewagamage US, Wijeratne S, et al. Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma. BMC Pediatr. 2019;19(1):411. doi:.
  37. Ahmet A, Mokashi A, Goldbloom EB, Huot C, Jurencak R, Krishnamoorthy P, et al. Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children. BMJ Paediatr Open. 2019;3(1):e000569. doi:.
  38. Ahmet A, Kim H, Spier S. Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol. 2011;7(1):13. doi:.
  39. Zöllner EW, Lombard CJ, Galal U, Hough S, Irusen EM, Weinberg E. Screening for hypothalamic-pituitary-adrenal axis suppression in asthmatic children remains problematic: a cross-sectional study. BMJ Open. 2013;3(8):e002935. doi:.
  40. Tse SM, Kelly HW, Litonjua AA, Van Natta ML, Weiss ST, Tantisira KG ; Childhood Asthma Management Program Research Group. Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. J Allergy Clin Immunol. 2012;130(1):53–60.e4. doi:.
  41. Loke YK, Gilbert D, Thavarajah M, Blanco P, Wilson AM. Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis. BMJ Open. 2015;5(11):e008554. doi:.
  42. Gray N, Howard A, Zhu J, Feldman LY, To T. Association Between Inhaled Corticosteroid Use and Bone Fracture in Children With Asthma. JAMA Pediatr. 2018;172(1):57–64. doi:.
  43. Fuhlbrigge AL, Kelly HW. Inhaled corticosteroids in children: effects on bone mineral density and growth. Lancet Respir Med. 2014;2(6):487–96. doi:.
  44. Chalitsios CV, Shaw DE, McKeever TM. Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Thorax. 2021;76(1):21–8. doi:.
  45. Hall SC, Agrawal DK. Vitamin D and Bronchial Asthma: An Overview of Data From the Past 5 Years. Clin Ther. 2017;39(5):917–29. doi:.
  46. Liu J, Dong YQ, Yin J, Yao J, Shen J, Sheng GJ, et al. Meta-analysis of vitamin D and lung function in patients with asthma. Respir Res. 2019;20(1):161. doi:.
  47. Kim MH, Rhee CK, Shim JS, Park SY, Yoo KH, Kim BY, et al. Inhaled Corticosteroids in Asthma and the Risk of Pneumonia. Allergy Asthma Immunol Res. 2019;11(6):795–805. doi:.
  48. Castellana G, Castellana M, Castellana C, Castellana G, Resta E, Carone M, et al. Inhaled Corticosteroids And Risk Of Tuberculosis In Patients With Obstructive Lung Diseases: A Systematic Review And Meta-Analysis Of Non-randomized Studies. Int J Chron Obstruct Pulmon Dis. 2019;14:2219–27. doi:.
  49. Liu VX, Winthrop KL, Lu Y, Sharifi H, Nasiri HU, Ruoss SJ. Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection. Ann Am Thorac Soc. 2018;15(10):1169–76. doi:.
  50. Levy J, Zalkinder I, Kuperman O, Skibin A, Apte R, Bearman JE, et al. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol. 1995;95(4):806–12. doi:.
  51. Behbehani AH, Owayed AF, Hijazi ZM, Eslah EA, Al-Jazzaf AM. Cataract and ocular hypertension in children on inhaled corticosteroid therapy. J Pediatr Ophthalmol Strabismus. 2005;42(1):23–7. doi:.
  52. Nootheti S, Bielory L. Risk of cataracts and glaucoma with inhaled steroid use in children. Compr Ophthalmol Update. 2006;7(1):31–9.
  53. Simons FE, Persaud MP, Gillespie CA, Cheang M, Shuckett EP. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet. 1993;342(8874):776–8. doi:.
  54. Szefler S, Weiss S, Tonascia J, Adkinson NF, Bender B, Cherniack R, et al., Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343(15):1054–63. doi:.
  55. Chang LS, Lee HC, Tsai YC, Shen LS, Li CL, Liu SF, et al. Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study. Oncotarget. 2017;8(62):105463–71. doi:.
  56. Yucel O, Eker Y, Nuhoglu C, Ceran O. Hemoglobin a1c levels in children with asthma using low dose inhaled corticosteroids. Indian Pediatr. 2009;46(4):300–3.
  57. Lim SH, Goh DY, Tan AY, Lee BW. Parents’ perceptions towards their child’s use of inhaled medications for asthma therapy. J Paediatr Child Health. 1996;32(4):306–9. doi:.
  58. Chan PW, DeBruyne JA. Parental concern towards the use of inhaled therapy in children with chronic asthma. Pediatr Int. 2000;42(5):547–51. doi:.
  59. Yoos HL, Kitzman H, McMullen A. Barriers to anti-inflammatory medication use in childhood asthma. Ambul Pediatr. 2003;3(4):181–90. doi:.<0181:BTAMUI>2.0.CO;2
  60. Gazala E, Sadka R, Bilenko N. Parents’ Fears and Concerns Toward Inhaled Corticosteroid Treatment for Their Asthmatic Children. Pediatr Asthma Allergy Immunol. 2005;18(2):82–7. doi:.
  61. Zhao J, Shen K, Xiang L, Zhang G, Xie M, Bai J, et al. The knowledge, attitudes and practices of parents of children with asthma in 29 cities of China: a multi-center study. BMC Pediatr. 2013;13(1):20. doi:.
  62. Ip KI, Hon KL, Tsang KYC, Leung TNH. Steroid phobia, Chinese medicine and asthma control. Clin Respir J. 2018;12(4):1559–64. doi:.
  63. Conn KM, Halterman JS, Fisher SG, Yoos HL, Chin NP, Szilagyi PG. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr. 2005;5(5):306–10. doi:.
  64. Conn KM, Halterman JS, Lynch K, Cabana MD. The impact of parents’ medication beliefs on asthma management. Pediatrics. 2007;120(3):e521–6. doi:.
  65. Koster ES, Raaijmakers JA, Vijverberg SJ, Maitland-van der Zee AH. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study. Pharmacoepidemiol Drug Saf. 2011;20(10):1064–72. doi:.
  66. Koster ES, Wijga AH, Koppelman GH, Postma DS, Brunekreef B, De Jongste JC, et al. Uncontrolled asthma at age 8: the importance of parental perception towards medication. Pediatr Allergy Immunol. 2011;22(5):462–8. doi:.
  67. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:.
  68. Lenney W, Bush A, Fitzgerald DA, Fletcher M, Ostrem A, Pedersen S, et al. Improving the global diagnosis and management of asthma in children. Thorax. 2018;73(7):662–9. doi:.
  69. Asthma UK. Paying to breathe: why unfair asthma prescription charges must be stopped. 2019.
  70. Hui RWH. Inhaled corticosteroid-phobia and childhood asthma: Current understanding and management implications. Paediatr Respir Rev. 2020;33:62–6. doi:.
  71. Gillissen A, Lecheler J. Kortikophobie beim Asthma bronchiale [Corticophobia in asthma]. Med Klin (Munich). 2003;98(8):417–22. Article in German. doi:.
  72. De Simoni A, Horne R, Fleming L, Bush A, Griffiths C. What do adolescents with asthma really think about adherence to inhalers? Insights from a qualitative analysis of a UK online forum. BMJ Open. 2017;7(6):e015245. doi:.
  73. Desager K, Vermeulen F, Bodart E. Adherence to asthma treatment in childhood and adolescence - a narrative literature review. Acta Clin Belg. 2018;73(5):348–55. doi:.
  74. Carroll WD, Wildhaber J, Brand PLP. Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey. Eur Respir J. 2012;39(1):90–6. doi:.
  75. Klok T, Kaptein AA, Duiverman EJ, Brand PL. Long-term adherence to inhaled corticosteroids in children with asthma: Observational study. Respir Med. 2015;109(9):1114–9. doi:.
  76. Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. doi:.
  77. Vasbinder EC, Belitser SV, Souverein PC, van Dijk L, Vulto AG, van den Bemt PM. Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children. Patient Prefer Adherence. 2016;10:531–8. doi:.
  78. Fleming L. Asthma exacerbation prediction: recent insights. Curr Opin Allergy Clin Immunol. 2018;18(2):117–23. doi:.
  79. Chongmelaxme B, Chaiyakunapruk N, Dilokthornsakul P. Association between adherence and severe asthma exacerbation: A systematic review and meta-analysis. J Am Pharm Assoc (2003). 2020;60(5):669–685.e2. doi:.
  80. Cambridge Dictionary. Phobia [17/03/2020]. Available from:
  81. Rubin BK. Asthma myths, controversies, and dogma. Paediatr Respir Rev. 2015;16(2):83–7. doi:.

Most read articles by the same author(s)